Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-034785)

Filing Details

Accession Number:: 0001209191-14-034785
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-16 19:05:20
Reporting Period:: 2014-05-14

Filing Date:: 2014-05-16
Accepted Time:: 2014-05-16 19:05:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1130591	Xenoport Inc	XNPT	Pharmaceutical Preparations (2834)	943330837

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202769	L Paul Berns	C/O Xenoport, Inc. 3410 Central Expressway Santa Clara CA 95051		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-14	5,000	$0.00	7,500	No	4	M	Direct
Common Stock	Disposition	2014-05-15	2,500	$3.66	5,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-employee director stock unit	Disposition	2014-05-14	5,000	$0.00	5,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2014.
Each restricted stock unit represents a contingent right to receive one share of XenoPort, Inc. common stock.
The restricted stock units shall cliff vest in full on the one-year anniversary of the grant date, May 14, 2013.